Maynards’ sale of Biopharmaceutical industry assets have featured a broad array of state-of-the-industry equipment and technology, networking and other capital assets. We have successfully generated extremely strong demand for sales of Biopharmaceutical assets from leading companies, recognizing and capitalizing on the opportunity for industry buyers to purchase high-quality late model biotech and pharma assets in excellent condition.
Buyers can review high-quality and late-model pharmaceutical and biotechnology assets at arranged on-site visits or via our comprehensive online catalogue listings. Maynards utilizes a fully integrated and industry-recognized online bidding platform that allows purchasers to safely and easily acquire assets at the click of a button, from the comfort of their offices anywhere in the world.
Maynards’ online and onsite Biopharma Auction or Liquidation sales may include equipment in the following categories: